Sure, who wouldn’t want to lose a few pounds? But what’s really driving Hollywood’s latest trend is the drug’s seemingly miraculous side benefits ...
Weight loss drug users are spending up to $690 less per year on groceries. Find out which foods they’re ditching the most.
Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.
The 25-year-old recently celebrate a major milestone in her career as she made her first appearance in the Sports Illustrated ...
Chief executive Emma Walmsley said ministers must work with the sector to boost investment amid growing concerns about doing ...
Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...
The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...
Novo Nordisk's U.S.-listed shares are rising 4% in premarket trading after the Ozempic and Wegovy maker's better-than-estimated quarterly results offset slower 2025 sales growth projections amid ...
Pharma giant Novo Nordisk, the company behind Wegovy and Ozempic, expects to launch six products in the next five years. Leading the pack of new drugs will be CagriSema.
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...
Nearly 2 in 3 people who sought to lose weight quit popular weight loss and diabetes drugs such as Ozempic or Victoza within one year, according to a new study. About 65% of those without diabetes ...
Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results